[ad_1] Vista Outdoor Inc.’s stock fell slightly early Monday, after the maker of sports and…
Tag:
Biopharmaceuticals
-
-
STOCK MARKET
Viking Therapeutics takes advantage of soaring stock price to issue fresh shares at a discount
by userby user[ad_1] Viking Therapeutics Inc., the clinical-stage biotech that wowed investors this week with promising data…
-
STOCK MARKET
Viking Therapeutics’ weight-loss drug data makes company takeover target
by userby user[ad_1] Viking Therapeutics Inc.’s stock rose another 8% Wednesday to extend its week-to-date gains to…
-
STOCK MARKET
Viking Therapeutics’ stock doubles after company reports positive results in trial of weight-loss drug
by userby user[ad_1] Viking Therapeutics Inc.’s stock soared 100% early Tuesday, after the company announced positive results…
-
STOCK MARKET
We’re spending more on leisure and travel. These 11 stocks will soak it up.
by userby user[ad_1] Leisure stocks are likely to outperform this year as emboldened consumers kick back and…
-
STOCK MARKET
AbbVie taps new CEO as it faces fresh competition for blockbuster drug Humira
by userby user[ad_1] AbbVie Inc.’s founding CEO Richard Gonzalez will step down July 1, the drugmaker said…
-
[ad_1] RAPT Therapeutics Inc. shares RAPT, +1.68% dropped more than 60% premarket on Tuesday after…
-
STOCK MARKET
Viking Therapeutics may offer investors a cheap entry to the weight-loss drug craze
by userby user[ad_1] Viking Therapeutics Inc.’s stock soared 17% to a record high on Thursday, after the…
-
STOCK MARKET
Amgen’s quarterly results top expectations despite Enbrel sales decline
by userby user[ad_1] Amgen Inc. on Tuesday reported fourth-quarter profits and sales that topped analysts’ expectations even as…
-
STOCK MARKET
Novartis to bolster its oncology portfolio with acquisition of MorphoSys
by userby user[ad_1] Novartis AG on Monday announced it has agreed to buy German biopharmaceutical company MorphoSys…